NO177055C - Analogous Process for the Preparation of Therapeutically Active 2-Oxetanones - Google Patents
Analogous Process for the Preparation of Therapeutically Active 2-OxetanonesInfo
- Publication number
- NO177055C NO177055C NO910729A NO910729A NO177055C NO 177055 C NO177055 C NO 177055C NO 910729 A NO910729 A NO 910729A NO 910729 A NO910729 A NO 910729A NO 177055 C NO177055 C NO 177055C
- Authority
- NO
- Norway
- Prior art keywords
- oxetanones
- preparation
- therapeutically active
- analogous process
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
Novel oxetanones inhibiting pancreatic lipase, of the formula <IMAGE> in which Q, R<1> and R<2> have the meaning given in the description, are disclosed, which are prepared starting from the corresponding beta -hydroxycarboxylic acids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH60490 | 1990-02-26 | ||
CH400590 | 1990-12-17 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO910729D0 NO910729D0 (en) | 1991-02-25 |
NO910729L NO910729L (en) | 1991-08-27 |
NO177055B NO177055B (en) | 1995-04-03 |
NO177055C true NO177055C (en) | 1995-07-12 |
Family
ID=25685091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO910729A NO177055C (en) | 1990-02-26 | 1991-02-25 | Analogous Process for the Preparation of Therapeutically Active 2-Oxetanones |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0444482B1 (en) |
JP (1) | JP2753403B2 (en) |
KR (1) | KR0183036B1 (en) |
AT (1) | ATE133167T1 (en) |
AU (1) | AU645291B2 (en) |
CA (1) | CA2035967C (en) |
DE (1) | DE59107262D1 (en) |
DK (1) | DK0444482T3 (en) |
ES (1) | ES2082869T3 (en) |
FI (1) | FI115054B (en) |
GR (1) | GR3019618T3 (en) |
HU (1) | HU218272B (en) |
IE (1) | IE72196B1 (en) |
IL (1) | IL97148A (en) |
MC (1) | MC2226A1 (en) |
NO (1) | NO177055C (en) |
NZ (1) | NZ237170A (en) |
PT (1) | PT96887B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
NL1004559C2 (en) * | 1996-11-18 | 1998-05-19 | Unilife | Butter. |
WO2001032616A2 (en) * | 1999-10-29 | 2001-05-10 | John Jason Gentry Mullins | Oxetanone derivatives |
US6348492B1 (en) * | 1999-10-29 | 2002-02-19 | 2Pro Chemical | Oxetanone derivatives |
US6342519B2 (en) * | 1999-10-29 | 2002-01-29 | 2 Pro Chemical | Oxetanone derivatives |
US7074822B2 (en) | 2004-02-23 | 2006-07-11 | Solvay Pharmaceuticals Gmbh | Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them |
DE102004009076A1 (en) * | 2004-02-23 | 2005-10-27 | Solvay Pharmaceuticals Gmbh | Alkylcarbamate-substituted β-lactones, processes and intermediates for their preparation, and medicaments containing these compounds |
CA2704462A1 (en) | 2007-10-31 | 2009-05-07 | Burnham Institute For Medical Research | Beta-lactone compounds |
CN111343999B (en) * | 2017-07-12 | 2022-03-01 | 梅约医学教育与研究基金会 | Compounds for reducing lipotoxic damage |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS608117B2 (en) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | New physiologically active substance esterastin and its production method |
GB2023604B (en) * | 1978-05-25 | 1982-07-28 | Microbial Chem Res Found | Physiologically active derivatives of esterastin and production thereof |
JPH0669130B2 (en) * | 1984-08-09 | 1994-08-31 | 三菱電機株式会社 | Delay line |
-
1991
- 1991-02-05 IL IL9714891A patent/IL97148A/en active IP Right Grant
- 1991-02-07 CA CA002035967A patent/CA2035967C/en not_active Expired - Fee Related
- 1991-02-15 ES ES91102151T patent/ES2082869T3/en not_active Expired - Lifetime
- 1991-02-15 AT AT91102151T patent/ATE133167T1/en not_active IP Right Cessation
- 1991-02-15 EP EP91102151A patent/EP0444482B1/en not_active Expired - Lifetime
- 1991-02-15 DE DE59107262T patent/DE59107262D1/en not_active Expired - Fee Related
- 1991-02-15 DK DK91102151.7T patent/DK0444482T3/en not_active Application Discontinuation
- 1991-02-20 NZ NZ237170A patent/NZ237170A/en unknown
- 1991-02-20 HU HU61/91A patent/HU218272B/en not_active IP Right Cessation
- 1991-02-20 AU AU71228/91A patent/AU645291B2/en not_active Ceased
- 1991-02-21 MC MC912172A patent/MC2226A1/en unknown
- 1991-02-22 JP JP3131730A patent/JP2753403B2/en not_active Expired - Fee Related
- 1991-02-25 IE IE63191A patent/IE72196B1/en not_active IP Right Cessation
- 1991-02-25 NO NO910729A patent/NO177055C/en unknown
- 1991-02-26 PT PT96887A patent/PT96887B/en not_active IP Right Cessation
- 1991-02-26 FI FI910925A patent/FI115054B/en not_active IP Right Cessation
- 1991-02-26 KR KR1019910003075A patent/KR0183036B1/en not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960401013T patent/GR3019618T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU218272B (en) | 2000-07-28 |
MC2226A1 (en) | 1993-02-02 |
AU7122891A (en) | 1991-08-29 |
IE72196B1 (en) | 1997-03-26 |
ES2082869T3 (en) | 1996-04-01 |
FI910925A (en) | 1991-08-27 |
AU645291B2 (en) | 1994-01-13 |
JPH0770099A (en) | 1995-03-14 |
DK0444482T3 (en) | 1996-05-06 |
KR0183036B1 (en) | 1999-05-01 |
EP0444482A3 (en) | 1991-12-04 |
PT96887B (en) | 1998-09-30 |
DE59107262D1 (en) | 1996-02-29 |
CA2035967C (en) | 2001-10-16 |
ATE133167T1 (en) | 1996-02-15 |
JP2753403B2 (en) | 1998-05-20 |
NO910729L (en) | 1991-08-27 |
FI115054B (en) | 2005-02-28 |
IL97148A (en) | 1996-11-14 |
EP0444482B1 (en) | 1996-01-17 |
EP0444482A2 (en) | 1991-09-04 |
NO910729D0 (en) | 1991-02-25 |
HUT56557A (en) | 1991-09-30 |
IE910631A1 (en) | 1991-08-28 |
FI910925A0 (en) | 1991-02-26 |
GR3019618T3 (en) | 1996-07-31 |
IL97148A0 (en) | 1992-05-25 |
KR910021391A (en) | 1991-12-20 |
NZ237170A (en) | 1993-12-23 |
NO177055B (en) | 1995-04-03 |
CA2035967A1 (en) | 1991-08-27 |
PT96887A (en) | 1991-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180718C (en) | Analogous Process for Preparation of Therapeutically Active Mercaptoacetylamide Derivatives | |
HUT53369A (en) | Process for producing substituted pyrrole and pharmaceutical compositions containing them | |
NO177055C (en) | Analogous Process for the Preparation of Therapeutically Active 2-Oxetanones | |
DK0393424T3 (en) | Process for the preparation of 2,7-diazabicyclo (3.3.0) octanes | |
HUT45058A (en) | Process for producing 6-hydroxy-methyl-carbapenem derivatives and pharmaceuticals comprising the same as active ingredient | |
DK0495953T3 (en) | 10- (1-Hydroxyethyl) -11-oxo-1-azatricyclo- (7.2.0.0.3.8) undec-2-ene-carboxylic acid esters and process for their preparation | |
CA2188176A1 (en) | 2,3-Dihydroxypropyl (1-Oxoalkyl)-2-Amino-2-Deoxyglucopyranoside, Process for Preparing the Same and Use Thereof | |
DK0751117T3 (en) | Preparation of bicyclohexane derivative | |
FR2715656B1 (en) | Process for the preparation of citraconic anhydride. | |
NO911237D0 (en) | PROCEDURE FOR THE PREPARATION OF HYDROXYMETHYL-INDOLIZIDINES AND -KINOLIZIDINES. | |
DK0614908T3 (en) | Process for the preparation of 3beta-aminocholanoic acid derivatives. | |
PT87563A (en) | PROCESS FOR THE PREPARATION OF VINYLCEPHALOSPORINS USEFUL AS MEDICAMENTS | |
DK0551653T3 (en) | Enantiomeric pure cis-2-oxa-5,8-diazabicyclo (4.3.0) nonanes and process for their preparation | |
DE69403615D1 (en) | Process for the preparation of epibatidine | |
ATE110720T1 (en) | PROCESS FOR THE PREPARATION OF 2-MERCAPTO-4-METHYL-1,3-THIAZOLE-5-YL-ACETIC ACID AND ITS ESTER. | |
DK0552631T3 (en) | Alpha-aryl-alpha-hydroxy-beta-imidazolinyl propionsyreamider | |
HUT57746A (en) | Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same | |
SE9003292D0 (en) | SHAFT FURNACE PROCESS FOR IRONMAKING |